Cargando…
Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105666/ https://www.ncbi.nlm.nih.gov/pubmed/36695969 http://dx.doi.org/10.1007/s11255-023-03469-5 |
| _version_ | 1785026259170885632 |
|---|---|
| author | Nestler, S. Peschel, C. Horstmann, A. H. Vahlensieck, W. Fabry, W. Neisius, A. |
| author_facet | Nestler, S. Peschel, C. Horstmann, A. H. Vahlensieck, W. Fabry, W. Neisius, A. |
| author_sort | Nestler, S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10105666 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Netherlands |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101056662023-04-17 Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections Nestler, S. Peschel, C. Horstmann, A. H. Vahlensieck, W. Fabry, W. Neisius, A. Int Urol Nephrol Correction Springer Netherlands 2023-01-25 2023 /pmc/articles/PMC10105666/ /pubmed/36695969 http://dx.doi.org/10.1007/s11255-023-03469-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Nestler, S. Peschel, C. Horstmann, A. H. Vahlensieck, W. Fabry, W. Neisius, A. Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections |
| title | Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections |
| title_full | Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections |
| title_fullStr | Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections |
| title_full_unstemmed | Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections |
| title_short | Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections |
| title_sort | correction to: prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of strovac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105666/ https://www.ncbi.nlm.nih.gov/pubmed/36695969 http://dx.doi.org/10.1007/s11255-023-03469-5 |
| work_keys_str_mv | AT nestlers correctiontoprospectivemulticentrerandomizeddoubleblindplacebocontrolledparallelgroupstudyontheefficacyandtolerabilityofstrovacinpatientswithrecurrentsymptomaticuncomplicatedbacterialurinarytractinfections AT peschelc correctiontoprospectivemulticentrerandomizeddoubleblindplacebocontrolledparallelgroupstudyontheefficacyandtolerabilityofstrovacinpatientswithrecurrentsymptomaticuncomplicatedbacterialurinarytractinfections AT horstmannah correctiontoprospectivemulticentrerandomizeddoubleblindplacebocontrolledparallelgroupstudyontheefficacyandtolerabilityofstrovacinpatientswithrecurrentsymptomaticuncomplicatedbacterialurinarytractinfections AT vahlensieckw correctiontoprospectivemulticentrerandomizeddoubleblindplacebocontrolledparallelgroupstudyontheefficacyandtolerabilityofstrovacinpatientswithrecurrentsymptomaticuncomplicatedbacterialurinarytractinfections AT fabryw correctiontoprospectivemulticentrerandomizeddoubleblindplacebocontrolledparallelgroupstudyontheefficacyandtolerabilityofstrovacinpatientswithrecurrentsymptomaticuncomplicatedbacterialurinarytractinfections AT neisiusa correctiontoprospectivemulticentrerandomizeddoubleblindplacebocontrolledparallelgroupstudyontheefficacyandtolerabilityofstrovacinpatientswithrecurrentsymptomaticuncomplicatedbacterialurinarytractinfections |